OncoSec Medical's IPO

OncoSec Medical raised a round of funding on September 03, 2008. Investors include Public.

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target and attack cancer. OncoSec's lead i…

Articles about OncoSec Medical's IPO: